Alnylam Pharmaceuticals
ALNY
#561
Rank
HK$348.42 B
Marketcap
HK$2,627
Share price
-0.94%
Change (1 day)
34.57%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company